Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Share-based Compensation (2021 - 2026)

Rani Therapeutics Holdings' Share-based Compensation history spans 6 years, with the latest figure at $2.1 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 46.9% to $2.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.0 million, a 38.1% decrease, with the full-year FY2025 number at $11.8 million, down 26.41% from a year prior.
  • Share-based Compensation came in at $2.1 million for Q1 2026, down from $2.2 million in the prior quarter.
  • The five-year high for Share-based Compensation was $5.1 million in Q2 2023, with the low at $2.1 million in Q1 2026.
  • Historically, Share-based Compensation has averaged $3.8 million across 5 years, with a median of $4.0 million in 2024.
  • Peak annual rise in Share-based Compensation hit 1309.93% in 2022, while the deepest fall reached 76.45% in 2022.
  • Year by year, Share-based Compensation stood at $4.5 million in 2022, then fell by 0.29% to $4.5 million in 2023, then fell by 11.03% to $4.0 million in 2024, then plummeted by 43.92% to $2.2 million in 2025, then dropped by 6.88% to $2.1 million in 2026.
  • Business Quant data shows Share-based Compensation for RANI at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $2.3 million in Q3 2025.